174 related articles for article (PubMed ID: 33154241)
1. Expected plazomicin susceptibility in India based on the prevailing aminoglycoside resistance mechanisms in Gram-negative organisms derived from whole-genome sequencing.
Pragasam AK; Jennifer SL; Solaimalai D; Muthuirulandi Sethuvel DP; Rachel T; Elangovan D; Vasudevan K; Gunasekaran K; Veeraraghavan B
Indian J Med Microbiol; 2020; 38(3 & 4):313-318. PubMed ID: 33154241
[TBL] [Abstract][Full Text] [Related]
2. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK and Ireland.
Taylor E; Sriskandan S; Woodford N; Hopkins KL
Int J Antimicrob Agents; 2018 Aug; 52(2):278-282. PubMed ID: 29596903
[TBL] [Abstract][Full Text] [Related]
4. Vegetable-Derived Carbapenemase-Producing High-Risk Klebsiella pneumoniae ST15 and Acinetobacter baumannii ST2 Clones in Japan: Coexistence of
Soliman AM; Nariya H; Tanaka D; Yu L; Hisatsune J; Kayama S; Kondo K; Sugai M; Shimamoto T; Shimamoto T
Appl Environ Microbiol; 2021 Apr; 87(9):. PubMed ID: 33674428
[TBL] [Abstract][Full Text] [Related]
5. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.
Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK
J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
7. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh.
Islam MA; Talukdar PK; Hoque A; Huq M; Nabi A; Ahmed D; Talukder KA; Pietroni MA; Hays JP; Cravioto A; Endtz HP
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2593-600. PubMed ID: 22422273
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.
Gür D; Hasdemir U; Çakar A; Çavuşoğlu İ; Çelik T; Aksu B;
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115092. PubMed ID: 32569921
[TBL] [Abstract][Full Text] [Related]
10. Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.
Eljaaly K; Alharbi A; Alshehri S; Ortwine JK; Pogue JM
Drugs; 2019 Feb; 79(3):243-269. PubMed ID: 30723876
[TBL] [Abstract][Full Text] [Related]
11. Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.
López-Diaz MD; Culebras E; Rodríguez-Avial I; Rios E; Viñuela-Prieto JM; Picazo JJ; Rodríguez-Avial C
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919895
[TBL] [Abstract][Full Text] [Related]
12. Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics.
Foudraine DE; Strepis N; Stingl C; Ten Kate MT; Verbon A; Klaassen CHW; Goessens WHF; Luider TM; Dekker LJM
Sci Rep; 2021 Jun; 11(1):12472. PubMed ID: 34127720
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant
Isler B; Falconer C; Vatansever C; Özer B; Çınar G; Aslan AT; Forde B; Harris P; Şimşek F; Tülek N; Demirkaya H; Menekşe Ş; Akalin H; Balkan İİ; Aydın M; Tigen ET; Demir SK; Kapmaz M; Keske Ş; Doğan Ö; Arabacı Ç; Yağcı S; Hazırolan G; Bakır VO; Gönen M; Saltoğlu N; Azap A; Azap Ö; Akova M; Ergönül Ö; Can F; Paterson DL
J Med Microbiol; 2022 Dec; 71(12):. PubMed ID: 36748503
[No Abstract] [Full Text] [Related]
14. Frequency of 16S ribosomal RNA methyltransferase detection among Escherichia coli and Klebsiella pneumoniae clinical isolates obtained from patients in Canadian hospitals (CANWARD, 2013-2017).
Walkty A; Karlowsky JA; Baxter MR; Adam HJ; Boyd D; Bharat A; Mulvey MR; Charles M; Bergevin M; Zhanel GG
Diagn Microbiol Infect Dis; 2019 Jun; 94(2):199-201. PubMed ID: 30638654
[TBL] [Abstract][Full Text] [Related]
15. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
16. Development of TaqMan real-time polymerase chain reaction for the detection of the newly emerging form of carbapenem resistance gene in clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
Manchanda V; Rai S; Gupta S; Rautela RS; Chopra R; Rawat DS; Verma N; Singh NP; Kaur IR; Bhalla P
Indian J Med Microbiol; 2011; 29(3):249-53. PubMed ID: 21860104
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
18. ARGONAUT II Study of the
Jacobs MR; Good CE; Hujer AM; Abdelhamed AM; Rhoads DD; Hujer KM; Rudin SD; Domitrovic TN; Connolly LE; Krause KM; Patel R; Arias CA; Kreiswirth BN; Rojas LJ; D'Souza R; White RC; Brinkac LM; Nguyen K; Singh I; Fouts DE; van Duin D; Bonomo RA;
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152078
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Maraki S; Mavromanolaki VE; Magkafouraki E; Moraitis P; Stafylaki D; Kasimati A; Scoulica E
Infection; 2022 Apr; 50(2):467-474. PubMed ID: 34854060
[TBL] [Abstract][Full Text] [Related]
20. Vertical and horizontal dissemination of an IncC plasmid harbouring rmtB 16S rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae.
Roch M; Sierra R; Sands K; Martins WMBS; Schrenzel J; Walsh TR; Gales AC; Andrey DO
J Glob Antimicrob Resist; 2021 Mar; 24():183-189. PubMed ID: 33373732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
